Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03076424 · ClinicalTrials.gov registry record
The Effect of Nutrient Intake on the Microbiome, Weight, and Glucoregulation (NI-MWG)
A clinical trial, sponsored by North Dakota State University.
- Completed
- Registry status
- 19
- Enrollment target
NCT03076424: Completed study, sponsored by North Dakota State University.
NCT03076424 is a clinical trial that has completed, run by North Dakota State University. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03076424 has completed, sponsored by North Dakota State University.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate a persons dietary intake and its effect on the gut microbiome and the association of those two variables on weight and glucoregulation. Specifically, the investigators will compare the gut microbiota, fasting glucose and insulin, c-peptide and hemoglobin A1-c in three groups of subjects: obese patients (BMI ≥ 30 kg/m2) with type 2 diabetes mellitus (T2DM), obese patients without T2DM, and normal weight lean controls without T2DM. Each patient will also complete a detailed dietary recall (ASA-24) to investigate the association with diet, microbiome and weight/glucoregulation.
Primary Outcome
The ratio of firmicutes to bacteroidetes will be the primary focus of the microbiome evaluation.
Interventions
- OTHER no intervention used
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2017-03-08 |
| Est. Completion | 2017-12-31 |
What the finished NCT03076424 record still lists
NCT03076424 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 19 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which no intervention used is the first listed.
NCT03076424 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03076424 about?
NCT03076424 is a clinical study titled "The Effect of Nutrient Intake on the Microbiome, Weight, and Glucoregulation (NI-MWG)". The purpose of this study is to investigate a persons dietary intake and its effect on the gut microbiome and the association of those two variables on weight and glucoregulation. Specifically, the investigators will compare the gut microbiota, fasting glucose and insulin, c-peptide and hemoglobin A...
What is the current status of trial NCT03076424?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2017-03-08. Estimated completion is 2017-12-31.
What interventions are being tested in trial NCT03076424?
The interventions under investigation include: no intervention used (OTHER).
Who is sponsoring clinical trial NCT03076424?
This trial is sponsored by North Dakota State University, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03207464 · 19 participants · Phase 1
Molecular Imaging of NET Using [C-11]MRB-PET in MS
- NCT04318717 · 19 participants · Phase 2
Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma
- NCT05103904 · 19 participants · Phase 2
Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplant
- NCT05607407 · 19 participants · Phase 2
Methimazole in Patients With Progressive Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI